Dr. Jacques A. Zephirin, MD

Dr. Zephirin practices at Surgical Associates in Camp Springs, Maryland.

Dr. Zephirin's NPI, 1013904952, was assigned on October 5, 2005. Dr. Zephirin holds Maryland license D0028639.

Dr. Zephirin's primary practice is Surgical Associates, at 5801 Allentown Rd Ste 502, Camp Springs, MD 20746. The practice phone is (240) 427-1630.

Dr. Zephirin's primary practice is Surgical Associates in Camp Springs, Maryland. The medical group on file is Surgical Associates, Chartered. Dmand AI also links Dr. Zephirin to 3 more group practices and clinics and 2 medical groups, each named with a free account. Dr. Zephirin's employer is on file too: a surgery center (asc).

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Zephirin practices, 4 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Zephirin's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Zephirin is licensed in Maryland.

CMS data shows 903 Medicare services from Dr. Zephirin across 17 procedure codes in 2024, for 168 Medicare patients. Medicare paid $901,119 for them. Every service was in an office.

CMS counts 168 Medicare patients who saw Dr. Zephirin in 2026. The largest group is 75 to 84, with 69 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 20% are also on Medicaid. Their average risk score is 2.24, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Zephirin's median patient age at 72, with 42% women.

In 2026, Dr. Zephirin wrote 258 Medicare Part D claims for 60 patients. 68% of them were for generic drugs. CMS names the drug for 208 of them, across 4 drugs with 11 or more claims each, at $71,892 in total drug cost. In 2023, CMS named 121 claims across 3 drugs.

Dr. Zephirin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 32 procedures of leg revascularization (restoring blood flow) by Dr. Zephirin, more than 90% of the clinicians it reports for that procedure.

CMS Open Payments shows 113 general payments to Dr. Zephirin from 21 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 58% of the total. Philips Electronics North America Corporation paid the most, $1,673.